ClinicalTrials.gg

MacroGenics clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 42 studies whose lead sponsor is MacroGenics. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 30, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare MacroGenics with AstraZeneca and GlaxoSmithKline →

Pipeline: 3 programs

Each counted once: 3 with a study MacroGenics leads registered in the last two years.

  • Phase 1
  • Phase 2

The 3 programs — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of MacroGenics’ own registered studies; MacroGenics’ own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs MacroGenics’ studies test, most open studies first — 8 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

3 of MacroGenics’ studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 2N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. 1J
  10. A
  11. S
  12. O
  13. N

Add all 3 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 18, 2026.

Started recruiting1

All 42 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now410%
  • Under way, not recruiting12%
  • Completed2252%
  • Stopped early1331%Terminated 12 · Withdrawn 1
  • Status unknown or other25%

Phase

  • Phase 127
  • Phase 215
  • Phase 35

Where

  • United States37
  • Spain10
  • Poland10
  • United Kingdom8
  • Australia7
  • Korea, Republic of6

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 515
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 126

By the year each study started; 2 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to MacroGenics.

  • MacroGenics
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    42 studies

Focus areas

Conditions MacroGenics leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 42 of 42.